SATURDAY, OCTOBER 21st, 2017


NCH Healthcare - Baker Hospital Downtown

Classroom 3 - Telford Building
350 7th Street North
Naples, FL 34102
Phone:  239-624-5000
Or
YOU MAY LOG IN AND LISTEN AND VIEW FROM YOUR OWN COMPUTER
 
COMPLIMENTARY SELF-PARKING AND REGISTRATION
Registration: 8:00 AM - 9:00 AM
Opioid Prescribing: 9:00 AM - 12 noon (EST)
 

8:00 AM

REGISTRATION / BREAKFAST

8:55 AM

CME DISCLOSURES AND SPONSOR ACKNOWLEDGEMENT

9:00 AM

OPIOID PRESCRIBING: SAFE PRACTICE, CHANGING LIVES = 3 HOURS SYMPOSIUM

Unit 1:  Assessing Patients for Treatment with ER/LA Opioid Analgesic Therapy

Unit 2:  Initiating Therapy, Modifying Dosing, and Discontinuing Use of ER/LA Opioid Analgesics

Unit 3:  Managing Therapy with ER/LA Opioid Analgesics

Unit 4:  Counseling Patients & Caregivers about Safe Use of ER/LA Opioid Analgesics

10:35 AM

BREAK

 

Unit 5: General Drug Information for ER/LA Opioid Analgesics

Unit 6: Specific Drug Information for ER/LA Opioid Analgesic Products

ASAM Unit: Is My Patient Opioid Addicted? - Diagnosis and Management

Outcomes and Evaluations, Questions

12 NOON

ADJOURN

This symposium is being offered either LIVE IN PERSON at the Hospital or you may LOG IN DIRECTLY FROM YOUR COMPUTER and listen to the presentation and view the ppt at the same time that it is being presented live. Please indicate your choice in the registration form below. If attending via computer, you will be contacted in advance with directions on how to log in on the day of the conference.

ACCREDITATION

 

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Addiction Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 3 AMA PRA Category 1 Credits™.

EXCEL Continuing Education is accredited by the Florida Board of Nursing and designates this activity 3 contact hours. Provider #50-619.


EDUCATIONAL OBJECTIVES for OPIOID PRESCRIBING

 
At the conclusion of this conference, you should be able to:
 

Describe appropriate patient assessment for treatment with ER/LA opioid analgesics, evaluating risks and potential benefits of ER/LA therapy as well as possible misuse
   

Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques as well as appropriate discontinuation strategies
   

Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics and properly use evidence-based tools while assessing for adverse effects
   

Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal
   

Review/assess general and product-specific drug information concerning ER/LA opioid analgesics and identifying potential adverse effects of ER/LA opioids
   
   

SUPPORTERS

 

RPC Commercial Support Disclosure Statement

Presented by ASAM, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.

This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please click on http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies.

This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.


Register Online


EXCEL CE complies with the Americans Disabilities Act. If any participant is in need of reasonable assistance, please FAX a written request to 305-598-7252 for consideration at least 2 weeks prior to the activity.